L-Nutra has raised US$36.5m in series D funding for what it describes as science-driven nutrition for longevity and nutrition as medicine. The round brings its series...
London-based biotech Engitix has raised US$25m in a Series A extension, with billionaire hedge fund founder Mike Platt backing the company for the second time. The...
TECregen has raised CHF 10m [£9,300,000] in seed financing to develop therapies aimed at rejuvenating the thymus, a gland that produces immune cells. The Basel-based biotechnology...
Corsera Health has raised US$80m in Series A funding to develop preventive RNAi medicines and AI tools to predict and prevent cardiovascular disease. The Boston-based company...
Higher intake of some food preservatives is linked with increased risks of type 2 diabetes and cancer, two studies suggest. The findings were based on diet...
We round up the latest ageing and longevity investment news. Regenerative cellular medicine company Celularity Inc has secured a US$10m financing package to support its healthy-ageing...
The US Food and Drug Administration (FDA) has cleared an automated brain fluid device designed to help ease intensive care nursing shortages. Seattle-based BrainSpace said its...
